A detailed history of Clear Harbor Asset Management, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 10,000 shares of LQDA stock, worth $110,100. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$110,100
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$8.9 - $14.11 $89,000 - $141,100
10,000 New
10,000 $100,000
Q3 2022

Oct 24, 2022

BUY
$3.73 - $8.39 $93,250 - $209,750
25,000 New
25,000 $136,000
Q2 2021

Aug 06, 2021

SELL
$2.51 - $3.11 $126,441 - $156,666
-50,375 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$2.6 - $5.79 $130,975 - $291,671
50,375 New
50,375 $149,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.